AT1-signalling in vascular smooth muscle

JRAAS - Journal of the Renin-Angiotensin-Aldosterone System

Volumn 1, Issue 2, 2000, Pages 125-130

  Hughes, Alun D ^a  

^a ST MARY S HOSPITAL   (United Kingdom)

Author keywords

Angiotensin II; AT1 receptor; Intracellular signalling; Tyrosine kinase; Vascular smooth muscle

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN RECEPTOR;

ANIMAL; EDITORIAL; HUMAN; INTRACELLULAR MEMBRANE; PHYSIOLOGY; SIGNAL TRANSDUCTION; VASCULAR SMOOTH MUSCLE;

ANIMALS; HUMANS; INTRACELLULAR MEMBRANES; MUSCLE, SMOOTH, VASCULAR; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTORS, ANGIOTENSIN; SIGNAL TRANSDUCTION;

EID: 0346677575     PISSN: 14703203     EISSN: None     Source Type: Journal    
DOI: 10.3317/jraas.2000.014     Document Type: Review

References (90)

1. Timmermans PBWM, Wong PC, Chiu AT et al. Angiotensin H receptors and angiotensin II receptor antagonists. Pharmacol Rev 1993;45:205-51.
2. Juul B, Aalkjaer C, Mulvany MJ. Responses of femoral resistance vessels to angiotensin in vitro. Eur J Pharmacol 1987;135:61-8.
3. Hafizi S, Chester AH, Allen SP, Morgan K, Yacoub MH. Growth response of human coronary smooth muscle cells to angiotensin II and influence of angiotensin AT1 receptor blockade. Coron Artery Dis 1998;9:167-75.
4. Mii S, Ware JA, Mallette BA, Kent KC. Effect of angiotensin II on human vascular smooth muscle cell growth. J Surg Res 1994;57:174-8.
5. Patel MK, Betteridge LJ, Hughes AD et al. Effect of angiotensin II on the expression of the early growth response gene c-fos and DNA synthesis in human vascular smooth muscle cells. J Hypertens 1996;14:341-7.
6. Parrott DP, Lockey PM, Bright CP. Comparison of the mitogenic activity of angiotensin II and serotonin on porcine arterial smooth muscle cells.Atherosclerosis 1991;88:213-8.
7. Berk BC, Vekshtein V, Gordon HM, Tsuda T.Angiotensin II-stimulated protein synthesis in cultured vascular smooth muscle cells. Hypertension 1989;13:305-14.
8. Touyz RM, Deng LY, He G, Wu XH, Schiffrin ELAngiotensin II stimulates DNA and protein synthesis in vascular smooth muscle cells from human arteries: role of extracellular signal-regulated kinases. J Hypertens 1999;17:907-16.
9. Bunkenburg B, van Amelsvoort T, Rogg H, Wood JM. Receptor-mediated effects of angiotensin II on growth of vascular smooth muscle cells from spontaneously hypertensive rats. Hypertension 1992;20:746-54.
10. Dubey RK, Flammer J, Luscher TF. Angiotensin II and insulin induce growth of ciliary artery smooth muscle: effects of AT1/AT2 antagonists. Invest Ophthalmol Vis Sci 1998; 39:2067-75.
11. Touyz RM, Schiffrin EL. Angiotensin II regulates vascular smooth muscle cell pH, contraction, and growth via tyrosine kinase-dependent signaling pathways. Hypertension 1997;30: 222-9.
12. Dubey RK, Roy A, Overbeck HW. Culture of renal arteriolar smooth muscle cells. Mitogenic responses to angiotensin II. Circ Res 1992;71:1143-52.
13. Gibbons GH, Pratt RE, Dzau VJ. Vascular smooth muscle cell hypertrophy vs. hyperplasia. Autocrine transforming growth factor-beta 1 expression determines growth response to angiotensin II. J Clin Invest 1992;90:456-61.
14. Stouffer GA, Owens GK.Angiotensin II-induced mitogenesis of spontaneously hypertensive rat-derived cultured smooth muscle cells is dependent on autocrine production of transforming growth factor-beta. Circ Res 1992;70:820-8.
15. Berk BC, Rao GN. Angiotensin II-induced vascular smooth muscle cell hypertrophy: PDGF A-chain mediates the increase in cell size. J Cell Physiol 1993;154:368-80.
16. Mangiarua EI, Palmer VL, Lloyd LL, McCumbee WD. Platelet-derived growth factor mediates angiotensin II-induced DNA synthesis in vascular smooth muscle cells. Arch Physiol Biochem 1997;105:151-7.
17. Ling S, Dai A, Ma YH et al. Matrix-dependent gene expression of EGR-1 and PDGF A regulate angiotensin II-induced proliferation in human vascular smooth muscle cells. Hypertension 1999;34:1141-6.
18. Servant MJ, Coulombe P, Turgeon B, Meloche S. Differential regulation of p27(Kip1) expression by mitogenic and hypertrophic factors: Involvement of transcriptional and posttranscriptional mechanisms. J Cell Biol 2000;148:543-56.
19. Oliverio MI, Kim HS, Ito M et al. Reduced growth, abnormal kidney structure, and type 2 (AT2) angiotensin receptor-mediated blood pressure regulation in mice lacking both AT1A and AT1B receptors for angiotensin II. Proc Natl Acad Sci USA 1998;95:15496-501.
20. Zhu Z, Zhang SH, Wagner C et al. Angiotensin AT1B receptor mediates calcium signaling in vascular smooth muscle cells of AT1A receptor-deficient mice. Hypertension 1998;31:1171-7.
21. Shirai H, Takahashi K, Katada T, Inagami T. Mapping of G protein coupling sites of the angiotensin II type 1 receptor. Hypertension 1995;25:726-30.
22. Sadoshima J-I, Izumo S. The heterotrimeric Gq protein-coupled angiotensin II receptor activates p21ras via the tyrosine kinase-Shc-Grb2-Sos pathway in cardiac myocytes. EMBO J 1996;15:775-87.
23. Ushio-Fukai M, Griendling KK, Akers M, Lyons PR, Alexander RW. Temporal dispersion of activation of phospholipase C-betal and -gamma isoforms by angiotensin II in vascular smooth muscle cells. Role of alphaq/11, alpha12, and beta gamma G protein subunits. J Biol Chem 1998;273:19772-7.
24. Graber SG, Figler RA, Garrison JC. Expression and purification of functional G protein alpha subunits using a baculovirus expression system.J Biol Chem 1992;267:1271-8.
25. Sadoshima J. Versatility of the angiotensin II type 1 receptor. Circ Res 1998;82:1352-5.
26. Macrez LN, Kalkbrenner F, Morel JL, Schultz G, Mironneau J G protein heterotrimer Galpha13beta1gamma3 couples the angiotensin AT1A receptor to increases in cytoplasmic Ca2+ in rat portal vein myocytes. J Biol Chem 1997;272:10095-102.
27. Berk BC, Corson MA. Angiotensin II signal transduction in vascular smooth muscle: role of tyrosine kinases. Circ Res 1997;80:607-16.
28. Hughes AD. Molecular and cellular mechanisms of action of angiotensin II (AT1) receptors in vascular smooth muscle. J Hum Hypertens 1998;12:275-81.
29. Horowitz A, Menice CB, Laporte R, Morgan KG. Mechanisms of smooth muscle contraction. Physiol Rev 1996;76:967-1003.
30. Griendling KK, Berk BC, Ganz P, Gimbrone-MA J, Alexander RW. Angiotensin II stimulation of vascular smooth muscle phosphoinositide metabolism. State of the art lecture. Hypertension 1987;9:III181-III185.
31. Heagerty AM, Ohanian J. Lipid-derived second-messengers in smooth muscle. J Hum Hypertens 1993;7:383-5.
32. Marrero MB, Paxton WG, Duff JL, Berk BC, Bernstein KE. Angiotensin II stimulates tyrosine phosphorylation of phospholipase C-gamma 1 in vascular smooth muscle cells. J Biol Chem 1994;269:10935-9.
33. Venema RC, Ju H, Venema VJ et al. Angiotensin II-induced association of phospholipase Cgamma1 with the G-protein-coupled AT1 receptor. J Biol Chem 1998;273:7703-8.
34. Di SJ, Raatz NS. Stimulation of G-protein coupled receptors in vascular smooth muscle cells induces tyrosine kinase dependent increases in calcium without tyrosine phosphorylation of phospholipase C gamma-1. FEBS Lett 1998;422:85-8.
35. Ohanian J, Liu G, Ohanian V, Heagerty AM. Lipid second messengers derived from glycerolipids and sphingolipids, and their role in smooth muscle function. Acta Physiol Scand 1998;164:533-48.
36. Lassegue B, Alexander RW, Clark M, Akers M, Griendling KK. Phosphatidylcholine is a major source of phosphatidic acid and diacylglycerol in angiotensin II-stimulated vascular smooth-muscle cells. Biochem J 1993;292:509-17.
37. Ohanian J, Izzard A, Littlewood M, Heagerty A. Regulation of diacylglycerol metabolism by vasoconstrictor hormones in intact small arteries. Circ Res 1993;72:1163-71.
38. Shinoda J, Kozawa O, Suzuki A, Watanabe TY, Oiso Y, Uematsu T. Mechanism of angiotensin II-induced arachidonic acid metabolite release in aortic smooth muscle cells: involvement of phospholipase D. Eur J Endocrinol 1997;136:207-12.
39. Ron D, Kazanietz MG. New insights into the regulation of protein kinase C and novel phorbol ester receptors. FASEB J 1999;13:1658-76.
40. Khalil RA, Morgan KG. Phenylephrine-induced translocation of protein kinase C and shortening of two types of vascular cells of the ferret. J Physiol Land 1992;455:585-99.
41. Liou YM, Morgan KG. Redistribution of protein kinase C isoforms in association with vascular hypertrophy of rat aorta. Am J Physiol 1994;267:C980-9.
42. Haller H, Lindschau C, Quass P, Distler A, Luft FC. Differentiation of vascular smooth muscle cells and the regulation of protein kinase C-alpha. Circ Res 1995;76:21-9.
43. Ohanian V, Ohanian J, Shaw L, Scarth S, Parker PJ, Heagerty AM. Identification of protein kinase C isoforms in rat mesenteric small arteries and their possible role in agonist-induced contraction. Circ Res 1996;78:806-12.
44. Jensen PE, Hughes A, Boonen HC, Aalkjaer C. Force, membrane potential, and pHi during activation of rat mesenteric small arteries with norepinephrine, potassium, aluminum fluoride, and phorbol ester. Effects of changes in pHi. Circ Res 1993;73:314-24.
45. Somlyo AP, Somlyo AV. Signal transduction by G-proteins, rho-kinase and protein phosphatase to smooth muscle and non-muscle myosin II. J Physiol (Lond) 2000;522:177-85.
46. Henrion D, Laher I, Laporte R, Bevan JA. Angiotensin II amplifies arterial contractile response to norepinephrine without increasing Ca++ influx: role of protein kinase C. J Pharmacol Exp Ther 1992;261:835-40.
47. Malarkey K, McLees A, Paul A, Gould GW, Plevin R. The role of protein kinase C in activation and termination of mitogen-activated protein kinase activity in angiotensin II-stimulated rat aortic smooth-muscle cells. Cell Signal 1996;8:123-9.
48. Liao DF, Monia B, Dean N, Berk BC. Protein kinase C-zeta mediates angiotensin II activation of ERK1/2 in vascular smooth muscle cells. J Biol Chem 1997;272:6146-50.
49. Ali S, Becker MW, Davis MG, Dorn GW. Dissociation of vasoconstrictor-stimulated basic fibroblast growth factor expression from hypertrophic growth in cultured vascular smooth muscle cells. Relevant roles of protein kinase C. Circ Res 1994;75:836-43.
50. Rosen B, Barg J, Zimlichman R. The effects of angiotensin II, endothelin-1, and protein kinase C inhibitor on DNA synthesis and intracellular calcium mobilization in vascular smooth muscle cells from young normotensive and spontaneously hypertensive rate. Am J Hypertens 1999;12:1243-51.
51. Taubman MB, Berk BC, Izumo S, Tsuda T, Alexander RW, Nadal Ginard B. Angiotensin II induces c-fos mRNA in aortic smooth muscle. Role of Ca2+ mobilization and protein kinase C activation. J Biol Chem 1989;264:526-30.
52. Leevers SJ, Vanhaesebroeck B, Waterfield MD. Signalling through phosphoinositide 3-kinases: the lipids take centre stage. Curr Opin Cell Biol 1999;11:219-25.
53. Saward I, Zahradka P. Angiotensin II activates phosphatidylinositol 3-kinase in vascular smooth muscle cells. Circ Res 1997;81:249-57.
54. Ushio-Fukai M, Alexander RW, Akers M et al. Reactive oxygen species mediate the activation of Akt/protein kinase B by angiotensin II in vascular smooth muscle cells. J Biol Chem 1999;274:22699-704.
55. Folli F, Kahn CR, Hansen H, Bouchie JL, Feener EP. Angiotensin II inhibits insulin signaling in aortic smooth muscle cells at multiple levels. A potential role for serine phosphorylation in insulin/angiotensin II crosstalk. J Clin Invest 1997;100:2158-69.
56. Linseman DA, Benjamin CW, Jones DA. Convergence of angiotensin II and platelet-derived growth factor receptor signaling cascades in vascular smooth muscle cells. J Biol Chem 1995;270:12563-8.
57. Molloy CJ, Taylor DS, Weber H. Angiotensin II stimulation of rapid protein tyrosine phosphorylation and protein kinase activation in rat aortic smooth muscle cells. J Biol Chem 1993;268:7338-45.
58. Turner CE, Pietras KM, Taylor DS, Molloy CJ. Angiotensin II stimulation of rapid paxillin tyrosine phosphorylation correlates with the formation of focal adhesions in rat aortic smooth muscle cells. J Cell Sci 1995;108:333-42.
59. Leduc I, Meloche S. Angiotensin II stimulates tyrosine phosphorylation of the focal adhesion-associated protein paxillin in aortic smooth muscle cells. J Biol Chem 1995;270: 4401-4.
60. Eguchi S, Numaguchi K, Iwasaki H et al. Calcium-dependent epidermal growth factor receptor transactivation mediates the angiotensin II-induced mitogen-activated protein kinase activation in vascular smooth muscle cells. J Biol Chem 1998;273:8890-6.
61. Ishida M, Marrero MB, Schieffer B, Ishida T, Bernstein KE, Berk BC. Angiotensin II activates pp60c-src in vascular smooth muscle cells. Circ Res 1995;77:1053-7.
62. Venema RC, Venema VJ, Eaton DC, Marrero MB. Angiotensin II-induced tyrosine phosphorylation of signal transducers and activators of transcription 1 is regulated by Janus-activated kinase 2 and Fyn kinases and mitogen-activated protein kinase phosphatase 1. J Biol Chem 1998;273:30795-800.
63. Marrero MB, Schieffer B, Paxron WG et al. Direct stimulation of Jak/STAT pathway by the angiotensin II AT1 receptor. Nature 1995;375:247-50.
64. Liang H, Venema VJ, Wang X, Ju H, Venema RC, Marrero MB. Regulation of angiotensin II-induced phosphorylation of STAT3 in vascular smooth muscle cells. J Biol Chem 1999;274:19846-51.
65. Saward L, Zahradka P. Angiotensin II activates phosphatidylinositol 3-kinase in vascular smooth muscle cells. Circ Res 1997;81:249-57.
66. Leduc I, Haddad G, Giasson E, Meloche S. Involvement of a tyrosine kinase pathway in the growth promoting effects of angiotensin II on aortic smooth muscle cells. J Pharmacol Exp Ther 1995;48:582-92.
67. Malloy LG,.Sauro MD. Tyrosine kinase inhibition suppresses angiotensin contraction in hypertensive and normotensive small resistance arteries. Life Sci 1996;58:L317-L324.
68. Watts SW, Florian JA, Monroe KM. Dissociation of angiotensin II-stimulated activation of mitogen-activated protein kinase kinase from vascular contraction. J Pharmacol Exp Ther 1998;286:1431-8.
69. Hollenberg MD. Tyrosine kinase pathways and the regulation of smooth muscle contractility. Trends Pharmacol Sci 1994;15:108-14.
70. Hughes AD, Wijetunge S. Role of tyrosine phosphorylation in excitation-contraction coupling in vascular smooth muscle. Acta Physiol Scand 1998;164:457-69.
71. Eguchi S, Iwasaki H, Inagami T et al. Involvement of PYK2 in angiotensin II signaling of vascular smooth muscle cells. Hypertension 1999;33:201-6.
72. Brinson AE, Harding T, Diliberto PA et al. Regulation of a calcium-dependent tyrosine kinase in vascular smooth muscle cells by angiotensin II and platelet-derived growth factor. Dependence on calcium and the actin cytoskeleton. J Biol Chem 1998;273:1711-8.
73. Sabri A, Govindarajan G, Griffin TM, Byron KL, Samarel AM, Lucchesi PA. Calcium- and protein kinase C-dependent activation of the tyrosine kinase PYK2 by angiotensin II in vascular smooth muscle. Circ Res 1998;83:841-51.
74. Eguchi S, Iwasaki H, Hirata Y et al. Epidermal growth factor receptor is indispensable for c-Fos expression and protein synthesis by angiotensin II. Eur J Pharmacol 1999;376:203-6.
75. Eguchi S, Matsumoto T, Motley ED, Utsunomiya H, Inagami T. Identification of an essential signaling cascade for mitogen-activated protein kinase activation by angiotensin II in cultured rat vascular smooth muscle cells. Possible requirement of Gq-mediated p21ras activation coupled to a Ca2+/calmodulin-sensitive tyrosine kinase. J Biol Chem 1996;271:14169-75.
76. Schmitz U, IshidaT, Ishida M et al. Angiotensin II stimulates p21-activated kinase in vascular smooth muscle cells: role in activation of JNK. Circ Res 1998;82:1272-8.
77. Griendling KK, Sorescu D, Ushio-Fukai M. NAD(P)H oxidase: role in cardiovascular biology and disease. Circ Res 2000;86:494-501.
78. Ishida T, Ishida M, Suero J, Takahashi M, Berk BC. Agonist-stimulated cytoskeletal reorganisation and signal transduction at focal adhesions in vascular smooth muscle cells require c-Src. J Clin Invest 1999;103:789-97.
79. Schieffer B, Drexler H, Ling BN, Marrero MB. G protein-coupled receptors control vascular smooth muscle cell proliferation via pp60c-src and p21ras. Am J Physiol 1997;272: C2019-C2030.
80. Ali MS, Sayeski PP, Dirksen LB, Hayzer DJ, Marrero MB, Bernstein KE. Dependence on the motif YIPP for the physical association of Jak2 kinase with the intracellular carboxyl tail of the angiotensin II AT1 receptor. J Biol Chem 1997;272:23382-8.
81. Sayeski PP, Ali MS, Safavi A et al. A catalytically active Jak2 is required for the angiotensin II-dependent activation of Fyn. J Biol Chem 1999;274:33131-42.
82. Heeneman S, Haendeler J, Saito Y, Ishida M, Berk BC. Angiotensin II induces transactivation of two different populations of the platelet-derived growth factor beta Receptor. KEY ROLE FOR THE p66 ADAPTOR PROTEIN Shc. J Biol Chem 2000;275:15926-32.
83. Servant MJ, Giasson E, Meloche S. Inhibition of growth factor-induced protein synthesis by a selective MEK inhibitor in aortic smooth muscle cells. J Biol Chem 1996;271:16047-52.
84. Xi XP, Graf K, Goetze S, Fleck E, Hsueh WA, Law RE. Central role of the MAPK pathway in ang II-mediated DNA synthesis and migration in rat vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 1999;19:73-82.
85. Takahashi T, Kawahara Y, Okuda M, Ueno H, Takeshita A, Yokoyama M. Angiotensin II stimulates mitogen-activated protein kinases and protein synthesis by a Ras-independent pathway in vascular smooth muscle cells. J Biol Chem 1997;272: 16018-22.
86. Garcha RS, Sever PS, Hughes AD. Role of Ca2+ channels, tyrosine kinase and MAP/ERK kinase kinase (MEK) in angiotensin II-induced contraction in human isolated resistance arteries. J Vasc Res 1998; 35 (Suppl 1): P13.
87. Touyz RM, El Mabrouk M, He G, Wu XH, Schiffrin EL. Mitogen-activated protein/extracellular signal-regulated kinase inhibition attenuates angiotensin II-mediatcd signaling and contraction in spontaneously hypertensive rat vascular smooth muscle cells. Circ Res 1999;84:505-15.
88. Touyz RM, He G, Deng LY, Schiffrin EL. Role of extracellular signal-regulated kinases in angiotensin II-stimulated contraction of smooth muscle cells from human resistance arteries. Circ 1999;99:392-9.
89. Hall A. Signal transduction pathways regulated by the Rho family of small GTPases. Br J Cancer 1999;80 Suppl 1:25-7.
90. Yamakawa T, Tanaka S, Numaguchi K et al. Involvement of Rho-kinase in angiotensin II-induced hypertrophy of rat vascular smooth muscle cells. Hypertension 2000;35:313-8.